Boston developer wins his 3rd office conversion approval in a year
A Boston developer won planning-board approval for his third office-to-housing conversion under a city tax-break program.
Gas station supplier Global Partners moving HQ to Newton
Gas station and convenience store supplier Global Partners LP said this week it will move its headquarters from Waltham to ...
Eater1d
A Luxe Sicilian Restaurant and Members-Only Club Is Coming to Downtown Boston
Plus, a highly anticipated Cambridge bakery aims for a spring debut, and more restaurant news to know this week ...
Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing
Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...
Bisnow1d
Newton Office Complex Lands 100K SF Headquarters Lease
Liquid fuel company Global Partners LP plans to relocate its headquarters from Waltham to Newton's newly renovated Riverside ...
A drone company just got ‘rare’ permission to fly over people and cars in Boston. Here’s why.
Canadian drone manufacturer Draganfly has already dipped a toe into Boston’s airspace with a futuristic medical drone ...
Global Partners to move HQ to Newton from Waltham
Waltham-based energy supplier Global Partners plans to move its headquarters to a recently renovated office complex in Newton ...
Office building on edge of Post Office Square is being prepped for apartments
Developers are hoping to turn a six-story office building in the heart of Boston’s Financial District into a 70-unit ...
CRISPR Therapeutics AG: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...
Vertex Reports Fourth Quarter and Full Year 2024 Financial Results
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2024, and provided ...